Engineers Gate Manager LP Chembio Diagnostics, Inc. Transaction History

Engineers Gate Manager LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.45 - $0.8 $43,203 - $76,805	-96,007 Reduced 84.69%	17,361 $11,000
Q1 2022 May 16, 2022	SELL	$0.66 - $1.23 $14,432 - $26,896	-21,867 Reduced 16.17%	113,368 $93,000
Q4 2021 Feb 14, 2022	BUY	$1.09 - $2.55 $147,406 - $344,849	135,235 New	135,235 $154,000
Q3 2021 Nov 15, 2021	SELL	$2.06 - $5.34 $65,363 - $169,438	-31,730 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.88 - $5.64 $11,615 - $22,746	-4,033 Reduced 11.28%	31,730 $94,000
Q1 2021 May 17, 2021	BUY	$3.4 - $7.97 $121,594 - $285,031	35,763 New	35,763 $126,000
Q3 2020 Nov 16, 2020	SELL	$3.28 - $5.93 $177,448 - $320,813	-54,100 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$3.18 - $15.54 $172,038 - $840,714	54,100 New	54,100 $176,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.